Labcorp is serving as the initial reference laboratory for Graves Gilbert. The laboratory service provider will help eligible Graves Gilbert patients detect suitable trials. Subsequently, the parties will join forces to rapidly enrol subjects into the trials. Patients who are part of the trial can choose hybrid care options using telemedicine and decentralised trial offerings of Circuit Clinical. These solutions help reduce the conventional issues associated with clinical research that prevent patients from participating in trials. Graves Gilbert CEO Chris Thorn said: “We look forward to continuing to serve our diverse communities by offering patients access to clinical trials and cutting-edge treatments all from the comfort of our offices, with the physicians they know and trust.”